Threat database

2 threats

Threat database
Severity	CVSS	Signals	Threat	Source	Published	Score and star
Medium	6.5	EPSS 0.2%	CVE-2026-50034Blood Glucose Monitoring System (Model No. APG-01 BT) · CWE-319 Medium6.5EPSS 0.2%2026-06-18GCVE DatabaseCVE-2026-50034 CVE-2026-50034 affects the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT). An attacker within Bluetooth Low Energy (BLE) communication range can passively intercept wireless traffic and obtain sensitive health-related information, specifically glucose measurement values. This vulnerability is classified under CWE-319, indicating the transmission of sensitive information in an unprotected manner. The CVSS 3.1 base score is 6.5, reflecting a medium severity level. No patches or fixes are currently documented for this vulnerability. The device is not a cloud service, so remediation depends on vendor updates or device replacement. EPSS 0.2%Vulnerability Apollo Pharmacy #cisa #cwe-319	GCVE Database	2026-06-18
Medium	6.5	EPSS 0.3%	CVE-2026-52866Blood Glucose Monitoring System (Model No. APG-01 BT) · CWE-862 Medium6.5EPSS 0.3%2026-06-18CVE Database V5CVE-2026-52866 An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection. EPSS 0.3%Vulnerability Apollo Pharmacy #cwe-862	CVE Database V5	2026-06-18

Showing 1–2 of 2 results